Anbio Biotechnology (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

6.50

-0.20 (-2.99%)

Apr 25, 2025, 4:00 PM EDT - Market closed

Anbio Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	4.33	2.25	10.01	2.54
Depreciation & Amortization	0	0.01	0.01	-
Loss (Gain) From Sale of Investments	-0.29	-0.16	-0.04	-
Change in Accounts Receivable	-4.62	-1.88	0.72	-0.72
Change in Inventory	-	0.35	-0.35	-
Change in Accounts Payable	-0.83	-0.58	-0.48	1.89
Change in Other Net Operating Assets	0.76	0.91	-5.41	0.47
Operating Cash Flow	-0.63	0.9	4.45	4.18
Operating Cash Flow Growth	-	-79.81%	6.40%	-
Investment in Securities	0.29	1.73	-1.53	-
Investing Cash Flow	0.29	1.73	-1.53	-
Other Financing Activities	0.1	-0.04	-	-
Financing Cash Flow	0.1	-0.04	-	-
Net Cash Flow	-0.25	2.59	2.92	4.18
Levered Free Cash Flow	-2.09	0.03	0.87	-
Unlevered Free Cash Flow	-2.09	0.03	0.87	-
Change in Net Working Capital	4.68	1.21	5.51	-

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q